发明名称 CDK2 ANTAGONISTS AS SHORT FORM C-MAF TRANSCRIPTION FACTOR ANTAGONISTS FOR TREATMENT OF GLAUCOMA.
摘要 <p>The short form version of c-Maf transcription factor is up-regulated in steroid-treated and transforming growth factor beta2-treated trabecular meshwork cells, and is present at elevated levels in glaucomatous versus normal trabecular meshwork cells and in glaucomatous versus normal optic nerve head tissue. Expression of short form c-Maf transcription factor under these conditions indicates a causal or effector role for the factor in primary open-angle and steroid-induced glaucoma pathogenesis. Antagonism of short form c-Maf transcription factor expression and/or activity in the trabecular meshwork or other ocular tissue is provided for inhibiting or alleviating glaucoma pathogenesis. Antagonists include cyclin-dependent kinase 2 inhibitors.</p>
申请公布号 MXPA06007062(A) 申请公布日期 2006.09.04
申请号 MX2006PA07062 申请日期 2004.12.21
申请人 ALCON, INC. 发明人 ALLAN R. SHEPARD
分类号 A61K31/52;A61K31/00;A61P27/06;(IPC1-7):A61K31/52 主分类号 A61K31/52
代理机构 代理人
主权项
地址